Literature DB >> 17273140

[Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation].

Alexandre Aubourg1, Louis d'Alteroche, Delphine Senecal, Catherine Gaudy, Yannick Bacq.   

Abstract

We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive. Reactivation occurred 9 months after chemotherapy with anti-CD 20 monoclonal antibodies and autologous hematopoietic stem cell transplantation for lymphoma had been performed. After non specific polyglobulin injections and treatment with adefovir dipivoxil, thrombocytopenia and viral replication were controlled. Seroconversion for both HBe and HBs occurred at 5 months. Adefovir was stopped 4 months later with no relapse during fifteen months of follow-up. This case shows that patients who have had previous contact with hepatitis B virus should be monitored if they become immunosuppressed, even if anti-HBs were initially present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273140     DOI: 10.1016/s0399-8320(07)89335-3

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

Review 1.  Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.

Authors:  Venessa Pattullo
Journal:  World J Hepatol       Date:  2015-05-08

2.  Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B.

Authors:  Alessandro Allegra; Giuseppa Penna; Andrea Alonci; Angela Granata; Arianna D'Angelo; Caterina Musolino
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

3.  Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

Authors:  Tara N Palmore; Neeral L Shah; Rohit Loomba; Brian B Borg; Uri Lopatin; Jordan J Feld; Farooq Khokhar; Glen Lutchman; David E Kleiner; Neal S Young; Richard Childs; A John Barrett; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-01       Impact factor: 11.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.